Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMPHIA child follow-up after prenatal progesterone exposure
NL-OMON27515Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in preterm birth comparing 17α-hydroxyprogesterone caproate with Placebo (2 arms). Primary endpoint: Cognition and behavior of the offspring. Started Sep 2020; status: recruiting.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NL-OMON27515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27515.